glp-1 shortages news november 2025 Weight Loss Drug Enforcement in 2025: State Attorneys General Step into a Growing Regulatory Gap How use of weight-loss drugs

We believe MEDI4166 is a novel molecule combining long acting agonist peptide and neutralising antibody activities to deliver a unique pharmacology profile for the management of T2D.

This in-depth look at Found covers pricing, insurance, coaching, and medication access

Considerations for employers who are thinking about covering GLP-1 drugs for weight loss.

In Canada, peptides are regulated as prescription medications and should only be administered under the guidance of a licensed healthcare professional

BODYBALANCE collagen peptides have been clinically-studied and proven to support muscle mass maintenance and growth during weight loss, especially when paired with regular physical activity.*^